| Susan Louise Donahue, DO | |
|
710 Common Pl Ste 700, Adel, IA 50003-8044 | |
| (515) 875-9760 | |
| (515) 875-9761 |
| Full Name | Susan Louise Donahue |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 31 Years |
| Location | 710 Common Pl Ste 700, Adel, Iowa |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891797445 | NPI | - | NPPES |
| 0282764 | Medicaid | IA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 02898 (Iowa) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercyone Des Moines Medical Center | Des moines, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| On With Life Inc | 4385553965 | 126 |
| The Iowa Clinic Pc | 4082513742 | 273 |
News Archive
Researchers at the University of Warwick, and the Kenya Medical Research Institute, Kilifi, Kenya, have found that respiratory syncytial virus (RSV) appears to be the predominant virus detected among infants and children hospitalized in Kenya with severe pneumonia, according to a study in the May 26 issue of JAMA. The contribution to this severe disease by an individual pathogen stresses the need for effective infant vaccination.
New Cleveland Clinic research shows for the first time that ibrutinib, an FDA-approved drug for lymphoma and leukemia, may also help treat the most common – and deadliest – type of brain tumor.
PROLOR Biotech, Inc., a company developing next generation biobetter therapeutic proteins, today announced that it has received regulatory clearance from the U.S. Food and Drug Administration (FDA) to conduct a Phase II clinical trial in the U.S. of its longer-acting version of human growth hormone, hGH-CTP.
Cases of the Zika virus, a mosquito-transmitted infection that may be linked to birth defects, are on the rise. Currently the majority of cases have been reported in the Americas, with Brazil reporting the highest numbers of cases. Although no local mosquito-borne cases have been reported in the United States, the Centers for Disease Control and Prevention has reported there have been travel-associated cases.
› Verified 8 days ago
| Entity Name | The Iowa Clinic Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346233178 PECOS PAC ID: 4082513742 Enrollment ID: O20040102000222 |
News Archive
Researchers at the University of Warwick, and the Kenya Medical Research Institute, Kilifi, Kenya, have found that respiratory syncytial virus (RSV) appears to be the predominant virus detected among infants and children hospitalized in Kenya with severe pneumonia, according to a study in the May 26 issue of JAMA. The contribution to this severe disease by an individual pathogen stresses the need for effective infant vaccination.
New Cleveland Clinic research shows for the first time that ibrutinib, an FDA-approved drug for lymphoma and leukemia, may also help treat the most common – and deadliest – type of brain tumor.
PROLOR Biotech, Inc., a company developing next generation biobetter therapeutic proteins, today announced that it has received regulatory clearance from the U.S. Food and Drug Administration (FDA) to conduct a Phase II clinical trial in the U.S. of its longer-acting version of human growth hormone, hGH-CTP.
Cases of the Zika virus, a mosquito-transmitted infection that may be linked to birth defects, are on the rise. Currently the majority of cases have been reported in the Americas, with Brazil reporting the highest numbers of cases. Although no local mosquito-borne cases have been reported in the United States, the Centers for Disease Control and Prevention has reported there have been travel-associated cases.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Susan Louise Donahue, DO Po Box 424, Des Moines, IA 50302-0424 Ph: (515) 875-9925 | Susan Louise Donahue, DO 710 Common Pl Ste 700, Adel, IA 50003-8044 Ph: (515) 875-9760 |
News Archive
Researchers at the University of Warwick, and the Kenya Medical Research Institute, Kilifi, Kenya, have found that respiratory syncytial virus (RSV) appears to be the predominant virus detected among infants and children hospitalized in Kenya with severe pneumonia, according to a study in the May 26 issue of JAMA. The contribution to this severe disease by an individual pathogen stresses the need for effective infant vaccination.
New Cleveland Clinic research shows for the first time that ibrutinib, an FDA-approved drug for lymphoma and leukemia, may also help treat the most common – and deadliest – type of brain tumor.
PROLOR Biotech, Inc., a company developing next generation biobetter therapeutic proteins, today announced that it has received regulatory clearance from the U.S. Food and Drug Administration (FDA) to conduct a Phase II clinical trial in the U.S. of its longer-acting version of human growth hormone, hGH-CTP.
Cases of the Zika virus, a mosquito-transmitted infection that may be linked to birth defects, are on the rise. Currently the majority of cases have been reported in the Americas, with Brazil reporting the highest numbers of cases. Although no local mosquito-borne cases have been reported in the United States, the Centers for Disease Control and Prevention has reported there have been travel-associated cases.
› Verified 8 days ago
London Michelle Muse, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1120 Greene St, Adel, IA 50003 Phone: 515-993-4656 Fax: 515-993-4532 |